Cowin Biotech: Human Septin9, SDC2, and NDRG4 gene methylation detection kits have obtained Class III medical device registration certificates
I'm PortAI, I can summarize articles.
Cowin Biotech announced that its wholly-owned subsidiary Jiangsu Jianwei Diagnostic Technology Co., Ltd. has developed the Septin9, SDC2, and NDRG4 gene methylation detection kits, which have received the Class III medical device registration certificate issued by the National Medical Products Administration. This is the company's first Class III registration certificate in the field of colorectal cancer auxiliary diagnosis, enhancing its competitiveness in related testing and gastrointestinal system diagnostics, and actively promoting the company's sales and business expansion
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments